
Loading

Loading
We use strictly necessary cookies to run this site, and analytics cookies to understand how it's used. See our Privacy Policy for details.
A GitHub-reviewed security advisory, not necessarily under active exploitation the way our CISA KEV advisories are, but a real, disclosed vulnerability in an open-source dependency.
Affected packages
Vulnerable: < 2026.6.6
Patched in 2026.6.6
Details
Browser CDP discovery could accept blocked WebSocket URLs. In affected versions, a lower-trust caller or configured input path could reach network destinations that should have been blocked by OpenClaw policy.
This advisory is scoped to the named feature and configuration. It does not change OpenClaw's trusted-operator model: authenticated Gateway operators, installed plugins, and intentional local execution surfaces remain trusted unless a separate policy, approval, allowlist, sandbox, or auth boundary is crossed.
When the affected feature is enabled and reachable, this could reach network destinations that should have been blocked by OpenClaw policy. Practical impact depends on the operator's configuration and whether lower-trust input can reach that path.
The first stable patched version is 2026.6.6.
Upgrade to a patched OpenClaw release when one is listed. Before upgrading, restrict the affected feature to trusted operators or disable it when it is not needed. As general hardening, keep channel and tool allowlists narrow, avoid sharing one Gateway between mutually untrusted users, and disable the affected feature when it is not needed.
EPSS, exploit probability
Low0.33%
estimated chance of real-world exploitation in the next 30 days, higher than 25.5% of every CVE FIRST.org scores
Refreshed 10/21/2026, via FIRST.org's EPSS model, not CVSS, this measures likelihood of exploitation, not how severe it would be.
Talk to us about this
Find out whether this dependency (or others like it) is actually reachable in your codebase.
Get help patching, or building dependency-scanning into your pipeline going forward.
A secure code review or supply chain review finds this before an advisory does.